SPX3,934.38-29.13 -0.74%
DIA335.37-3.09 -0.91%
IXIC11,004.62-77.39 -0.70%

Maxim Group Downgrades ABVC BioPharma to Hold

Benzinga · 11/16/2022 08:16
Maxim Group analyst Jason McCarthy downgrades ABVC BioPharma (NASDAQ:ABVC) from Buy to Hold.